{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T14:40:55Z","timestamp":1659969655468},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Gerontol Geriat"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00391-022-02077-9","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T11:07:07Z","timestamp":1656068827000},"page":"421-430","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Atypische Parkinson-Syndrome im Alter"],"prefix":"10.1007","volume":"55","author":[{"given":"Bernhard","family":"Iglseder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00fcdiger","family":"Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"key":"2077_CR1","first-page":"S53","volume":"7","author":"M Goedert","year":"2017","unstructured":"Goedert\u00a0M, Jakes\u00a0R, Spillantini\u00a0MG (2017) The synucleinopathies: twenty years on. J\u00a0Parkinsons Dis 7:S53\u2013S71","journal-title":"J Parkinsons Dis"},{"key":"2077_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/brain\/aww230","volume":"140","author":"M Goedert","year":"2017","unstructured":"Goedert\u00a0M, Masuda-Suzukake\u00a0M, Falcon\u00a0B (2017) Like prions: the propagation of aggregated tau and alpha-synuclein in neurodegeneration. Brain 140:266\u2013278","journal-title":"Brain"},{"key":"2077_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.parkreldis.2021.09.008","volume":"90","author":"E Leveille","year":"2021","unstructured":"Leveille\u00a0E, Ross\u00a0OA, Gan-Or\u00a0Z (2021) Tau and MAPT genetics in tauopathies and synucleinopathies. Parkinsonism Relat Disord 90:142\u2013154","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"2077_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/cns.13068","volume":"25","author":"DV Moretti","year":"2019","unstructured":"Moretti\u00a0DV (2019) Available and future treatments for atypical parkinsonism. A systematic review. CNS Neurosci Ther 25(2):159\u2013174","journal-title":"CNS Neurosci Ther"},{"key":"2077_CR5","doi-asserted-by":"publisher","first-page":"572976","DOI":"10.3389\/fneur.2020.572976","volume":"11","author":"U Saeed","year":"2020","unstructured":"Saeed\u00a0U, Lang\u00a0AE, Masellis\u00a0M (2020) Neuroimaging advances in Parkinson\u2019s disease and atypical Parkinsonian syndromes. Front Neurol 11:572976","journal-title":"Front Neurol"},{"issue":"14","key":"2077_CR6","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/mds.26054","volume":"29","author":"G Respondek","year":"2014","unstructured":"Respondek\u00a0G, Stamelou\u00a0M, Kurz\u00a0C, Ferguson\u00a0LW, Rajput\u00a0A, Chiu\u00a0WZ et\u00a0al (2014) The phenotypic spectrum of progressive supranuclear palsy: a\u00a0retrospective multicenter study of 100 definite cases. Mov Disord 29(14):1758\u20131766","journal-title":"Mov Disord"},{"key":"2077_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/bs.irn.2019.10.003","volume":"149","author":"G Respondek","year":"2019","unstructured":"Respondek\u00a0G, Stamelou\u00a0M, Hoglinger\u00a0GU (2019) Classification of atypical parkinsonism per pathology versus phenotype. Int Rev Neurobiol 149:37\u201347","journal-title":"Int. Rev. Neurobiol."},{"issue":"10","key":"2077_CR8","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00115-008-2559-2","volume":"79","author":"A Strzelczyk","year":"2008","unstructured":"Strzelczyk\u00a0A, Moller\u00a0JC, Stamelou\u00a0M, Matusch\u00a0A, Oertel\u00a0WH (2008) Atypical Parkinson syndromes. Nervenarzt 79(10):1203\u20131220 (quiz 21\u20132)","journal-title":"Nervenarzt"},{"issue":"1","key":"2077_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/ene.13412","volume":"25","author":"AB Deutschlander","year":"2018","unstructured":"Deutschlander\u00a0AB, Ross\u00a0OA, Dickson\u00a0DW, Wszolek\u00a0ZK (2018) Atypical parkinsonian syndromes: a\u00a0general neurologist\u2019s perspective. Eur J Neurol 25(1):41\u201358","journal-title":"Eur J Neurol"},{"issue":"1","key":"2077_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1440-1789.2003.00543.x","volume":"24","author":"K Wakabayashi","year":"2004","unstructured":"Wakabayashi\u00a0K, Takahashi\u00a0H (2004) Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration. Neuropathology 24(1):79\u201386","journal-title":"Neuropathology"},{"issue":"9","key":"2077_CR11","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1002\/mds.25509","volume":"28","author":"M Stamelou","year":"2013","unstructured":"Stamelou\u00a0M, Quinn\u00a0NP, Bhatia\u00a0KP (2013) \u201cAtypical\u201d atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy\u2014a diagnostic guide. Mov Disord 28(9):1184\u20131199","journal-title":"Mov Disord"},{"issue":"1","key":"2077_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith\u00a0IG, Boeve\u00a0BF, Dickson\u00a0DW, Halliday\u00a0G, Taylor\u00a0JP, Weintraub\u00a0D et\u00a0al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology 89(1):88\u2013100","journal-title":"Neurology"},{"issue":"2","key":"2077_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(19)30153-X","volume":"19","author":"JP Taylor","year":"2020","unstructured":"Taylor\u00a0JP, McKeith\u00a0IG, Burn\u00a0DJ, Boeve\u00a0BF, Weintraub\u00a0D, Bamford\u00a0C et\u00a0al (2020) New evidence on the management of Lewy body dementia. Lancet Neurol 19(2):157\u2013169","journal-title":"Lancet Neurol"},{"key":"2077_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/bs.irn.2019.10.004","volume":"149","author":"A Fanciulli","year":"2019","unstructured":"Fanciulli\u00a0A, Stankovic\u00a0I, Krismer\u00a0F, Seppi\u00a0K, Levin\u00a0J, Wenning\u00a0GK (2019) Multiple system atrophy. Int Rev Neurobiol 149:137\u2013192","journal-title":"Int Rev Neurobiol"},{"issue":"5","key":"2077_CR15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/mds.27018","volume":"32","author":"EK St Louis","year":"2017","unstructured":"St Louis\u00a0EK, Boeve\u00a0AR, Boeve\u00a0BF (2017) REM sleep behavior disorder in Parkinson\u2019s disease and other synucleinopathies. Mov Disord 32(5):645\u2013658","journal-title":"Mov Disord"},{"issue":"4","key":"2077_CR16","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s00415-018-9121-3","volume":"266","author":"V Chelban","year":"2019","unstructured":"Chelban\u00a0V, Bocchetta\u00a0M, Hassanein\u00a0S, Haridy\u00a0NA, Houlden\u00a0H, Rohrer\u00a0JD (2019) An update on advances in magnetic resonance imaging of multiple system atrophy. J\u00a0Neurol 266(4):1036\u20131045","journal-title":"J Neurol"},{"key":"2077_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/bs.irn.2019.10.013","volume":"149","author":"N Giagkou","year":"2019","unstructured":"Giagkou\u00a0N, Hoglinger\u00a0GU, Stamelou\u00a0M (2019) Progressive supranuclear palsy. Int Rev Neurobiol 149:49\u201386","journal-title":"Int Rev Neurobiol"},{"issue":"7","key":"2077_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","volume":"16","author":"AL Boxer","year":"2017","unstructured":"Boxer\u00a0AL, Yu\u00a0JT, Golbe\u00a0LI, Litvan\u00a0I, Lang\u00a0AE, Hoglinger\u00a0GU (2017) Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol 16(7):552\u2013563","journal-title":"Lancet Neurol"},{"key":"2077_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.parkreldis.2020.04.014","volume":"73","author":"DG Coughlin","year":"2020","unstructured":"Coughlin\u00a0DG, Litvan\u00a0I (2020) Progressive supranuclear palsy: advances in diagnosis and management. Parkinsonism Relat Disord 73:105\u2013116","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"2077_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11940-016-0422-5","volume":"18","author":"R Lamb","year":"2016","unstructured":"Lamb\u00a0R, Rohrer\u00a0JD, Lees\u00a0AJ, Morris\u00a0HR (2016) Progressive supranuclear palsy and corticobasal degeneration: pathophysiology and treatment options. Curr Treat Options Neurol 18(9):42","journal-title":"Curr Treat Options Neurol"},{"issue":"4","key":"2077_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1590\/s1980-5764-2016dn1004003","volume":"10","author":"JB Parmera","year":"2016","unstructured":"Parmera\u00a0JB, Rodriguez\u00a0RD, Studart Neto\u00a0A, Nitrini\u00a0R, Brucki\u00a0SMD (2016) Corticobasal syndrome: a diagnostic conundrum. Dement neuropsychol 10(4):267\u2013275","journal-title":"Dement neuropsychol"},{"issue":"3","key":"2077_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1001\/jamaneurol.2019.4347","volume":"77","author":"E Jabbari","year":"2020","unstructured":"Jabbari\u00a0E, Holland\u00a0N, Chelban\u00a0V, Jones\u00a0PS, Lamb\u00a0R, Rawlinson\u00a0C et\u00a0al (2020) Diagnosis across the spectrum of progressive supranuclear palsy and corticobasal syndrome. JAMA Neurol 77(3):377\u2013387","journal-title":"JAMA Neurol"},{"issue":"3","key":"2077_CR23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/mds.27344","volume":"33","author":"JA Palma","year":"2018","unstructured":"Palma\u00a0JA, Kaufmann\u00a0H (2018) Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord 33(3):372\u2013390","journal-title":"Mov Disord"},{"issue":"5","key":"2077_CR24","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1055\/s-0040-1713844","volume":"40","author":"EA Coon","year":"2020","unstructured":"Coon\u00a0EA (2020) Autonomic dysfunction in the synucleinopathies. Semin Neurol 40(5):492\u2013501","journal-title":"Semin Neurol"},{"key":"2077_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.parkreldis.2019.09.026","volume":"67","author":"C Raccagni","year":"2019","unstructured":"Raccagni\u00a0C, Goebel\u00a0G, Gassner\u00a0H, Granata\u00a0R, Ndayisaba\u00a0JP, Seebacher\u00a0B et\u00a0al (2019) Physiotherapy improves motor function in patients with the Parkinson variant of multiple system atrophy: a prospective trial. Parkinsonism Relat Disord 67:60\u201365","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"2077_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1177\/0269215519877235","volume":"34","author":"SC Slade","year":"2020","unstructured":"Slade\u00a0SC, Finkelstein\u00a0DI, McGinley\u00a0JL, Morris\u00a0ME (2020) Exercise and physical activity for people with progressive supranuclear palsy: a\u00a0systematic review. Clin Rehabil 34(1):23\u201333","journal-title":"Clin Rehabil"},{"issue":"4","key":"2077_CR27","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1176\/appi.neuropsych.19020044","volume":"32","author":"H Xu","year":"2020","unstructured":"Xu\u00a0H, Bao\u00a0Z, Liang\u00a0D, Li\u00a0M, Wei\u00a0M, Ge\u00a0X et al (2020) Speech and language therapy for voice problems in parkinson\u2019s disease: a meta-analysis. J\u00a0Neuropsychiatry Clin Neurosci 32(4):344\u2013351","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"s1","key":"2077_CR28","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.3233\/JPD-202105","volume":"10","author":"E Tenison","year":"2020","unstructured":"Tenison\u00a0E, Henderson\u00a0EJ (2020) Multimorbidity and frailty: tackling complexity in parkinson\u2019s disease. J\u00a0Parkinsons Dis 10(s1):S85\u2013S91","journal-title":"J Parkinsons Dis"},{"issue":"4","key":"2077_CR29","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s00115-014-4181-9","volume":"86","author":"W Maetzler","year":"2015","unstructured":"Maetzler\u00a0W, Drey\u00a0M, Jacobs\u00a0AH (2015) Sarcopenia and frailty in neurology. Nervenarzt 86(4):420\u2013430","journal-title":"Nervenarzt"},{"issue":"5","key":"2077_CR30","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1093\/brain\/awn065","volume":"131","author":"SS O\u2019Sullivan","year":"2008","unstructured":"O\u2019Sullivan\u00a0SS, Massey\u00a0LA, Williams\u00a0DR, Silveira-Moriyama\u00a0L, Kempster\u00a0PA, Holton\u00a0JL et al (2008) Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 131(5):1362\u20131372","journal-title":"Brain"}],"container-title":["Zeitschrift f\u00fcr Gerontologie und Geriatrie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-022-02077-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00391-022-02077-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-022-02077-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T14:14:56Z","timestamp":1659968096000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00391-022-02077-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2077"],"URL":"https:\/\/doi.org\/10.1007\/s00391-022-02077-9","relation":{},"ISSN":["0948-6704","1435-1269"],"issn-type":[{"value":"0948-6704","type":"print"},{"value":"1435-1269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]},"assertion":[{"value":"23 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>B<\/b><b>.\u00a0Iglseder:<\/b> A. Finanzielle Interessen: Honorare: Fa. Gr\u00fcnenthal, Referent bei Webinaren im Dezember 2020 und im September 2021 zu Nebenwirkungen zentralwirksamer Analgetika (insgesamt \u20ac\u202f2\u202fT); \u00d6sterreichische Gesundheitskasse, Video Polypharmazie, September 2021 (insgesamt \u20ac\u202f1,5\u202fT); | \u00d6sterreichische Gesundheitskasse, Mitherausgeber Ratgeber Demenz, M\u00e4rz 2020 bis November 2021 (insgesamt \u20ac\u202f3\u202fT).\u00a0\u2013 Aktienpaket Fa. Roche.\u00a0\u2013 B. Nichtfinanzielle Interessen: Klinikleitung Geriatrie Uniklinikum Salzburg; President elect \u00d6GGG | Mitgliedschaften: \u00d6GN, \u00d6GSF, Salzburger \u00c4rztegesellschaft, Gesellschaft der \u00c4rzte in Wien, \u00d6AV. <b>R.\u00a0Lange:<\/b> A. Finanzielle Interessen: R. Lange gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B. Nichtfinanzielle Interessen: Oberarzt der Notaufnahme Neurologie, Klinikum N\u00fcrnberg\/Paracelsus Medizinische Privatuniversit\u00e4t | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Neurologie, International Movement Disorders Society.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}